- Corporate Officers - K
- Kim Peter S
Insider Trading History of Kim Peter S
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kim Peter S since 2008.
This trader's CIK number is 1181180.
At the time of last reporting, Kim Peter S was the Director of Entrada Therapeutics, Inc.. (stock ticker symbol TRDA).
Also see all insider trading activities at Entrada Therapeutics, Inc..
Note that in the past
KIM PETER S also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Entrada Therapeutics, Inc. (TRDA) by Kim Peter S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | TRDA | 17,636 | $242,270 | 0 | $0 | 11,918 | $72,223 |
Yearly summary of insider trading at Merck & Co Inc (MRK) by Kim Peter S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | MRK | 0 | $0 | 0 | $0 | 32,500 | $0 |
| 2008 | MRK | 0 | $0 | 0 | $0 | 66,667 | $0 |
Yearly summary of insider trading at Merck & Co., Inc. (MRK) by Kim Peter S
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | MRK | 0 | $0 | 420,000 | $19,110,840 | 420,000 | $12,653,340 |
| 2011 | MRK | 0 | $0 | 0 | $0 | 21,600 | $0 |
| 2010 | MRK | 0 | $0 | 0 | $0 | 37,600 | $0 |
Insider trading activities at 3 companies by Kim Peter S:
1. Entrada Therapeutics, Inc. (TRDA)
2. Merck & Co Inc (MRK)
3. Merck & Co., Inc. (MRK)
Table 1. Insider trading of Entrada Therapeutics, Inc. (TRDA) by Kim Peter S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-06-03 | TRDA | Option Ex | 11,918 | 6.06 | 72,223 |
| 2024-05-08 | TRDA | Buy | 2,276 | 14.04 | 31,964 |
| 2024-05-09 | TRDA | Buy | 2,200 | 14.25 | 31,341 |
| 2024-04-08 | TRDA | Buy | 2,600 | 13.57 | 35,289 |
| 2024-03-28 | TRDA | Buy | 1,512 | 13.75 | 20,794 |
| 2024-03-22 | TRDA | Buy | 3,118 | 13.76 | 42,900 |
| 2024-03-25 | TRDA | Buy | 3,180 | 13.36 | 42,472 |
| 2024-03-26 | TRDA | Buy | 2,750 | 13.64 | 37,510 |
Table 2. Insider trading of Merck & Co Inc (MRK) by Kim Peter S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-03-03 | MRK | Option Ex | 32,500 | .00 | 0 |
| 2008-02-25 | MRK | Option Ex | 66,667 | .00 | 0 |
Table 3. Insider trading of Merck & Co., Inc. (MRK) by Kim Peter S
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-11-05 | MRK | Option Ex | 420,000 | 30.13 | 12,653,340 |
| 2012-11-05 | MRK | Sale | 420,000 | 45.50 | 19,110,840 |
| 2011-02-28 | MRK | Option Ex | 21,600 | .00 | 0 |
| 2010-03-02 | MRK | Option Ex | 37,600 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Kim Peter S
(Director of Entrada Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.